Abstract
Many patients with Bladder Pain Syndrome (BPS) have sensitivities to various comestibles. There are a variety of pathologic mechanisms suggested to be responsible for the relationship between dietary intake and symptom exacerbation. Based upon the current literature, certain food types affect symptoms of BPS and comorbid conditions more than others, suggesting that a controlled method to determine dietary sensitivities, such as the elimination diet, may play an important first-line role in the management of the BPS patient. When considering dietary intervention in patients with BPS, it is of utmost importance to take into account comorbid conditions when counseling patients.
Keywords
- Neuropathic Pain
- Irritable Bowel Syndrome
- Chronic Fatigue Syndrome
- Carpal Tunnel Syndrome
- Irritable Bowel Syndrome Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- BPS:
-
Bladder pain syndrome
- CFS:
-
Chronic fatigue syndrome
- FMS:
-
Fibromyalgia syndrome
- GAG:
-
Glycosaminoglycan
- IBS:
-
Irritable bowel syndrome
- IC:
-
Interstitial cystitis
- ICA:
-
Interstitial Cystitis Association
- OSPI:
-
O’Leary–Sant pain index
- PUF:
-
Pain urgency, frequency scale
References
Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol. 2004;172:1242.
Erickson DR, Morgan KC, Ordille S, et al. Nonbladder related symptoms in patients with interstitial cystitis. J Urol. 2001;166:557.
Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology. 1997;49:2.
Rodríguez MB, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2009;182:2123.
Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology. 2007;69:9.
Hauser PJ, Dozmorov MG, Bane BL, et al. Abnormal expression of differentiation related proteins in the urothelium of patients with interstitial cystitis. J Urol. 2008;179:764.
Hurst RE, Moldwin RM, Mulholland SG. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology. 2007;69:17.
Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010;29:77.
Rudick CN, Chen MC, Monglu AK, et al. Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1191.
Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology. 2007;69:24.
Wesselmann U. Neurogenic inflammation and chronic pelvic pain. World J Urol. 2001;3:180.
Shorter B, Lesser M, Moldwin R, et al. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007;178:145.
Gillespie L. You don’t have to live with cystitis! New York: Rawson Associates; 1996.
Koziol JA, Clark DC, Gittes RF, et al. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149:465.
Nguan C, Franciosi LG, Butterfield N, et al. A prospective, double-blind, randomized cross-over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis. BJU Int. 2005;95:91.
Clemens JQ, Brown SO, Kosloff L, et al. Predictors of symptoms severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006;175:963.
Yamada T. Significance of complications of allergic diseases in young patients with interstitial cystitis. Int J Urol. 2003;10:S56.
Bologna RA, Gomelsky A, Lukban JC, Whitmore KE, et al. The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology. 2001;57(6):119.
Theoharides TC, Sant GR. A pilot open label study of cystoprotek in interstitial cystitis. Int J Immunopathol Pharmacol. 2005;18:183.
Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol. 2005;174:590.
Marinkovic SP, Moldwin R, Gillen LM, et al. The management of interstitial cystitis or painful bladder syndrome in women. BMJ. 2009;339:337.
Parsons CL, Greene RA, Chung M, et al. Abnormal urinary potassium metabolism in patients with interstitial cystitis. J Urol. 2005;173:1182.
Parsons CL, Greenberger M, Gabal L, et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol. 1998;159:1862.
Parsons CL, Zupkas P, Parsons JK. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology. 2001;57:428.
Gillespie L. Metabolic appraisal of the effects of dietary modifications on hypersensitive bladder symptoms. Br J Urol. 1992;72:293.
Bird ET, Parker BD, Kim HS, et al. Caffeine ingestion and lower urinary tract symptoms in healthy volunteers. Neurourol Urodyn. 2005;24:611.
Osborne J. Wine, beer & spirits – do they trigger IC flares? A patient survey reveals surprising results. IC Optimist. 2010;7:15.
Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg. 2011;17:36.
Clemens JQ, Meenan RT, O’KeeffeRosetti MC, et al. Case–control study of medical comorbidities in women with interstitial cystitis. J Urol. 2008;179(6):2222.
Rodríguez MA, Afari N, Buchwald DS, National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2009;182:2123.
Mahan L, Escott-Stump S. Krause’s food and nutrition therapy. St. Louis: Saunders; 2008.
Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 2004;146:1.
Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc. 2009;109:1204.
Bijkerk CJ, de Wit NJ, Muris JW, et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ. 2009;339:b3154.
Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case–control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73:52.
Heitkemper M, Jarrett M. Overlapping conditions in women with irritable bowel syndrome. Urol Nurs. 2005;25:25.
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160.
Nimnuan C, Rabe-Hesketh S, Wessely S, et al. How many functional somatic syndromes? J Psychosom Res. 2001;51:549.
Haugen M, Kjeldsen-Kragh J, Nordvåg BY, et al. Diet and disease symptoms in rheumatic diseases–results of a questionnaire based survey. Clin Rheumatol. 1991;10:401.
Holton KF, Kindler LL, Jones KD. Potential dietary links to central sensitization in fibromyalgia: past reports and future directions. Rheum Dis Clin North Am. 2009;35:409.
Arranz LI, Canela MA, Rafecas M. Fibromyalgia and nutrition, what do we know? Rheumatol Int. 2010;30:1417.
Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010;184:1358.
Fukuda K, Straus SE, Hickle I, et al. The chronic fatigue syndrome; a comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953.
Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev. 2001;6:450.
Brouwers FM, Van Der Wef S, Bleijenberg G, et al. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial. Q J Med. 2002;95:677.
Teitelbaum JE, Johnson C, St Cyr J. The use of d-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006;12:857.
Moldwin R. The interstitial cystitis survival guide. Oakland: New Harbinger; 2000.
Dell JR, Mokrzycki ML, Jayne CJ. Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice. Eur J Obstet Gynecol Reprod Biol. 2009;144:105.
Carrico DJ, Sherer KL, Peters KM. The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia. Urol Nurs. 2009;29:233.
Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia; a historical perspective. J Reprod Med. 2004;49:772.
Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med. 1991;36:879.
Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol. 1997;177:509.
Harlow BL, Abenhaim HA, Vitonis AF, et al. Influence of dietary oxalates on the risk of adult-onset vulvodynia. J Reprod Med. 2008;53:171.
Novi JM, Jeronis S, Srinivas S, et al. Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case–control study. J Urol. 2005;174:937.
Stahl LA, Begg DP, Weisinger RE, et al. The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs. 2008;9:57.
Dinan T, Siggins L, Scully P, et al. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res. 2009;43:471.
Treede RD, Jensen TS, Campbell JN, et al. Redefinition of neuropathic pain and a grading system for clinical use; consensus statement on clnical and research diagnostic criteria. Neurology. 2008;70:1630.
Ko GD, Nowacki NB, Arseneau L, et al. Omega-3 fatty acids for neuropathic pain: case series. Clin J Pain. 2010;26:168.
Gormsen L, Rosenberg R, Bach FW, et al. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain. 2010;14:127.
Jansen SC, van Dusseldorp M, Botterna KC, et al. Intolerance to dietary biogenic amines: a review. Ann Allergy Asthma Immunol. 2003;91:233.
Schiapparelli P, Allais G, Castagnoli Gabellari I, et al. Non-pharmacological approach to migraine prophylaxs: part II. Neurol Sci. 2010;31:S137.
Alpay K, Ertas M, Orhan EK, et al. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia. 2010;30:829.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Friedlander, J.I., Shorter, B., Moldwin, R.M. (2013). Diet and Its Role in Bladder Pain Syndrome and Comorbid Conditions. In: Nordling, J., Wyndaele, J., van de Merwe, J., Bouchelouche, P., Cervigni, M., Fall, M. (eds) Bladder Pain Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6929-3_19
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6929-3_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-6928-6
Online ISBN: 978-1-4419-6929-3
eBook Packages: MedicineMedicine (R0)